Port Gamble, WA -- Apr 19, 2007 -- /prbuzz/ -- Honored by the Arlington Institute of Wash DC as a nominee for the prestigious INDEX Award, EM-PROBE Technologies medical devices are yeilding exciting results in medical research.

A doctoral dissertation study completed at the University of Rio De Janeiro neurophysiology department reported that a crushed sciatic nerve injury demonstrated such notable response to EMpulse SOLO healing stimulus that the definitive study will require a minimum number (20 active and 20 sham) to establish confidence at the 95% level as to the results seen in this pilot study.

Most impressive was the result was seen with single 30 minute treatments for 14 days. No technology has ever demonstrated such rapid healing response previously. This study also supports similar conclusions reached by NASA investigator Thomas Goodwin in his watershed study on human nerve tissue response to nanosecond technology similar to that EPT manufactures for human tissue restoration and pain relief.

About EM-PROBE Technologies

Sports medicine specialist and researcher, Dr. Glen Gordon founded EM-PROBE Technologies in 2001. Dr. Gordon, the first MD in the United States approved to treat humans with soft tissue injury and arthritis using nanosecond pulsed electromagnetic field technology, chaired the first symposium on free radical damage in sports injury presented at an annual meeting of The American College of Sports Medicine. An invited speaker at a 2006 W.H.O. international meeting on integrative medicine, he conducts research on his company's miniaturized, FDA-approved, hand held device, the result of 25 years of research and development. EMpulse is effective for the relief of pain and inflammation in a variety of conditions. For more information about EM-PROBE Technologies, please visit www.em-probe.com, or call 1-888-697-9996.